curis.com - CRIS Operating profit EBITDA
Curis, Inc. remains in the R&D stage without commercial sales, which is confirmed by the recorded EBITDA level. The cash flow dynamics on this chart demonstrate the absence of a market product, where 0.00 serves as the final level marker. Patents for leukemia inhibitors provide business protection, yet investors face liquidity shortages and the risk of FDA trial halts due to side effects.
Curis - analytical breakdowns and key metrics (CRIS)
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
- earnings and market ratios statistics:
CRIS - Net Income|Expected Net Income Curis, Inc.|CRIS - P/E Multiple|Market Cap to Projected Earnings Curis Inc.|CRIS - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Curis|CRIS - Operating profit EBITDA|Net earnings per share for the last 12 months Curis|CRIS - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months curis.com|CRIS - Earnings growth in current year|Expected earnings per share growth for next year Curis, Inc.
Analysis of all company metrics:Curis, Inc.
To find a balance between asset quality and business valuation, it is essential to evaluate cash flow from operating activities before interest and taxes, which determines a company's actual ability to generate internal resources. In the case of Curis, Inc. (CRIS), the absence of commercial products makes the monitoring of operating profit in cash terms an indicator of dependence on external financing and partner payments.
Who Curis, Inc. competes with
ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Operating profit EBITDA PSNL|Operating profit before deduction of amortization erasca.com ERAS|Delcath Systems - Operating profit before deduction of amortization|Operating profit EBITDA Y-mAbs Therapeutics Inc YMAB|AURA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization CADL (Candel Therapeutics)|ARAY: Operating profit EBITDA|SLS - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Actuate Therapeutics|Citius Oncology Inc. (CTOR) - Operating income before deduction of amortization|Operating profit before deduction of amortization HURA (TuHURA Biosciences, Inc.)|TARA (Protara Tx) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA FATE (Fate Therapeutics, Inc.)|Operating income before deduction of amortization Aadi Bioscience, Inc. (WHWK)|TCRX - Profit before payment of interest, taxes and amortization|CSBR (Champions Oncology) - Operating profit before amortization|XBIT: Operating profit EBITDA|Operating profit before deduction of amortization CEL-SCI|Operating profit before deduction of amortization OSTX|radiopharmtheranostics.com (RADX) - Operating income before deduction of amortization|Operating profit EBITDA ARTV|Operating profit before deduction of amortization adlainortye.com ANL|Profit before payment of interest, taxes and amortization Veru Pharma VERU|Income before deduction of interest, taxes and amortization TPST|Xilio - Operating profit EBITDA|Operating income before deduction of amortization Renovaro Inc. RENB|muraloncology.com (MURA) - Profit before payment of interest, taxes and amortization|KAPA - Operating income before deduction of amortization|OKUR (OnKure Therapeutics, Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization CytoMed (GDTC)|Operating profit EBITDA APLM|Operating profit EBITDA tharimmune.com (THAR)|Profit before payment of interest, taxes and amortization Advanced Biomed ADVB|GNPX: Operating profit before amortization|Calidi Bio - Operating profit EBITDA|sunshinebiopharma.com (SBFM) - Operating profit before deduction of amortization|XBIO: Operating profit EBITDA|Profit before interest, taxes and amortization salariuspharma.com (SLRX)|Profit before payment of interest, taxes and amortization Purple Biotech Ltd.|AONC: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization BGNE (BeOne Medicines)|CKPT (Checkpoint Therapeutics Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ELEV (Elevation Oncology)|ICAD - Operating profit before deduction of amortization|IKNA: Operating profit before deduction of amortization|NTBL - Operating profit EBITDA|viracta.com (VIRX) - Profit before payment of interest, taxes and amortization|MorphoSys Corporation - Income before deduction of interest, taxes and amortization|NAYA (NAYA Biosciences) - Operating profit EBITDA|Profit before interest, taxes and amortization ascentage.com AAPGV
